NuGene International, Inc.NuGene International, Inc.NuGene International, Inc.

NuGene International, Inc.

No trades
See on Supercharts
Market capitalization
‪8.04 M‬USD
−0.0154USD
‪−6.55 M‬USD
‪2.01 M‬USD
‪780.30 M‬
Beta (1Y)
5.75

About NuGene International, Inc.

CEO
David Štybr
Headquarters
New York
Employees (FY)
11
Founded
2013
ISIN
US67052F1021
FIGI
BBG005YQJ3N1
Livento Group, Inc. focuses on acquisition and development of companies with disruptive business models in film, content, and technology sectors. It engages in production of premium film and television content for international audiences across multiple genres under brand BOXO Productions. The firm is involved in the artificial intelligence and machine learning technology business and real estate finance and development activities. Livento Group was founded by David Stybr on October 30, 2013 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NUGN is 0.0100 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NuGene International, Inc. stocks are traded under the ticker NUGN.
NUGN stock is 19.05% volatile and has beta coefficient of 5.75. Check out the list of the most volatile stocks — is NuGene International, Inc. there?
Yes, you can track NuGene International, Inc. financials in yearly and quarterly reports right on TradingView.
NUGN stock has risen by 2.04% compared to the previous week, the month change is a 11.11% rise, over the last year NuGene International, Inc. has showed a 80.95% decrease.
NUGN net income for the last quarter is ‪−405.67 K‬ USD, while the quarter before that showed ‪−1.18 M‬ USD of net income which accounts for 65.64% change. Track more NuGene International, Inc. financial stats to get the full picture.
Today NuGene International, Inc. has the market capitalization of ‪8.04 M‬, it has decreased by 4.76% over the last week.
No, NUGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NUGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NuGene International, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NUGN reached its all-time high on Feb 27, 2015 with the price of 5.0000 USD, and its all-time low was 0.0001 USD and was reached on Mar 7, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 11.00 employees. See our rating of the largest employees — is NuGene International, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NuGene International, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NuGene International, Inc. stock shows the sell signal. See more of NuGene International, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NuGene International, Inc. EBITDA is ‪−3.01 M‬ USD, and current EBITDA margin is −234.14%. See more stats in NuGene International, Inc. financial statements.